Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership(A) |
2022-11-14 9:04 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Chione Ltd Czernik Marcin Hadjimichael Andreas Nikolaou Anastasis Smolokowski Wiaczeslaw 10% Owner |
0 | $0 | 3,456,597 (Direct) |
View |
Ownership |
2022-11-09 9:07 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Chione Ltd Czernik Marcin Hadjimichael Andreas Smolokowski Wiaczeslaw 10% Owner |
0 | $0 | 3,456,597 (Direct) |
View |
Ownership |
2022-11-09 8:51 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner |
0 | $0 | 888,130 (Direct) |
View |
Ownership |
2022-11-09 8:30 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Devroe Eric Chief Operating Officer |
0 | $0 | 220,701 (Direct) |
View |
Ownership |
2022-11-09 8:30 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
0 | $0 | 1,421,008 (Indirect) |
View |
Ownership |
2022-11-09 8:30 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Blume-Jensen Peter President and CEO |
0 | $0 | 1,601,465 (Direct) |
View |
Ownership |
2022-11-09 8:30 pm |
N/A 2031-03-24 |
Acrivon Therapeutics Inc. | ACRV | Gamelin Erick Chief Medical Officer |
0 | $0 | 162,206 (Direct) |
View |
Ownership |
2022-11-09 8:30 pm |
N/A N/A |
Acrivon Therapeutics Inc. | ACRV | Masson Kristina EVP - Business Operations |
0 | $0 | 1,601,465 (Direct) |
View |
Ownership |
2022-11-09 8:30 pm |
N/A 2032-06-28 |
Acrivon Therapeutics Inc. | ACRV | Holm-Jorgensen Rasmus Chief Financial Officer |
0 | $0 | 192,619 (Direct) |
View |